AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

AFC-HD AMS Life Science Balance Sheet

Financials in millions JPY. Fiscal year is September - August.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	9,697	11,303	12,172	11,182	10,377	9,222
Cash & Short-Term Investments	9,697	11,303	12,172	11,182	10,377	9,222
Cash Growth	-14.50%	-7.14%	8.85%	7.76%	12.52%	95.17%
Receivables	3,453	2,915	2,792	2,828	2,563	2,184
Inventory	7,769	7,022	5,981	4,362	3,728	3,851
Other Current Assets	1,158	1,085	1,149	1,503	457	595
Total Current Assets	22,077	22,325	22,094	19,875	17,125	15,852
Property, Plant & Equipment	22,510	21,335	19,416	17,144	15,922	16,011
Long-Term Investments	3,479	2,876	2,857	2,558	2,808	2,115
Goodwill	1,673	1,870	2,349	1,289	1,338	1,491
Other Intangible Assets	207	148	167	92	118	161
Long-Term Deferred Tax Assets	-	170	146	112	35	120
Other Long-Term Assets	2	2	1	1	2	2
Total Assets	49,948	48,726	47,030	41,071	37,348	35,752

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Accounts Payable	3,656	3,623	3,586	3,265	3,414	2,966
Accrued Expenses	326	197	188	170	152	196
Short-Term Debt	10,057	9,472	9,078	7,914	6,816	3,962
Current Portion of Long-Term Debt	9,106	8,964	519	303	182	1,027
Current Income Taxes Payable	280	475	506	368	175	646
Other Current Liabilities	3,369	3,261	3,745	2,834	2,479	3,005
Total Current Liabilities	26,794	25,992	17,622	14,854	13,218	11,802
Long-Term Debt	4,544	5,475	13,293	11,319	10,136	9,691
Pension & Post-Retirement Benefits	1,061	1,013	1,022	991	1,000	974
Long-Term Deferred Tax Liabilities	-	215	229	258	265	298
Other Long-Term Liabilities	1,123	833	908	493	285	327
Total Liabilities	33,522	33,528	33,074	27,915	24,904	23,092

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Common Stock	2,207	2,134	2,131	2,131	2,131	2,131
Additional Paid-In Capital	2,697	2,651	2,650	2,638	2,640	2,438
Retained Earnings	11,078	10,427	9,415	8,589	7,880	7,420
Treasury Stock	-	-255	-275	-353	-305	-141
Comprehensive Income & Other	165	118	11	103	92	69
Total Common Equity	16,147	15,075	13,932	13,108	12,438	11,917
Minority Interest	279	123	24	48	6	743
Shareholders' Equity	16,426	15,198	13,956	13,156	12,444	12,660
Total Liabilities & Equity	49,948	48,726	47,030	41,071	37,348	35,752

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Total Debt	23,707	23,911	22,890	19,536	17,134	14,680
Net Cash (Debt)	-14,010	-12,608	-10,718	-8,354	-6,757	-5,458
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-976.82	-896.23	-762.76	-594.48	-478.56	-387.93
Filing Date Shares Outstanding	14.56	14.09	14.06	13.97	14.04	14.19
Total Common Shares Outstanding	14.56	14.09	14.06	13.97	14.04	14.19
Working Capital	-4,717	-3,667	4,472	5,021	3,907	4,050
Book Value Per Share	1109.03	1069.82	990.63	938.19	886.21	839.75
Tangible Book Value	14,267	13,057	11,416	11,727	10,982	10,265
Tangible Book Value Per Share	979.90	926.61	811.73	839.35	782.47	723.34
Order Backlog	-	1,014	933.61	891.23	718.94	714.19

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error